Woodline Partners LP Eliem Therapeutics, Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.6 - $10.2 $57,699 - $226,358
22,192 New
22,192 $157,000
Q3 2022

Nov 14, 2022
SELL
$2.72 - $3.97 $399,198 - $582,653
-146,764 Reduced 39.31%
226,604 $732,000
Q4 2021

Feb 14, 2022
SELL
$8.61 - $20.47 $119,300 - $283,632
-13,856 Reduced 3.58%
373,368 $3.91 Million
Q3 2021

Nov 15, 2021
BUY
$14.45 - $28.61 $5.6 Million - $11.1 Million
387,224 New
387,224 $6.96 Million

Others Institutions Holding ELYM

# of Institutions
69
Shares Held
53.1M
Call Options Held
0
Put Options Held
0
View Full List

About Eliem Therapeutics, Inc.

ELYM Quotes by TradingView
  • Ticker ELYM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,567,700
  • Market Cap $109M
  • Description
  • Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...
More about ELYM
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email